LogicBio Therapeutics, Inc.
We are a genome editing company focused on developing medicines to durably treat rare diseases in patients with significant unmet medical need using GeneRide, our proprietary technology platform.
$12.00 - $14.00
Jefferies, Barclays, William Blair, Chardan
To view the prospectus for LogicBio Therapeutics, Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277